Cegedim and Skila Form Alliance to Co-Market Solutions to Life Science Industry
BEDMINSTER, N.J. – May 27, 2008 For the nation’s pharmaceutical companies, July 1 may be as dreaded as the April 15 tax deadline.
On that date, all companies providing promotional gifts or other payments to Cegedim and Skila have formed a global alliance to co-market their products and services to medical and marketing teams in the life sciences industry.
The co-marketing alliance between Cegedim, a world leader in pharmaceutical CRM and strategic healthcare industry data, and Skila, a leader in integrated Marketing and Medical solutions, creates the industry’s most complete suite of knowledge and effectiveness solutions for global Medical and Marketing teams.
The global alliance addresses the growing need for pharmaceutical companies to better understand their clients; streamline their global teams and business processes; ensure corporate transparency and internal medical and regulatory compliance; and get the most out of their key initiatives.
“There is significant customer value in the partnership between Cegedim and Skila, particularly in the areas of medical and marketing effectiveness,” says Laurent Schockmel, CFO of Cegedim Americas. “Our customers are always looking for innovative end-to-end solutions in these areas, and this alliance will allow us to provide that.”
The collaboration between Cegedim and Skila will focus on delivering extensive customer value by helping new and existing customers address the challenges and opportunities of launching new products and managing all aspects of thought leader relationships. “By working together, we offer our clients the industry’s most unique, robust and sustainable solutions for identifying and building lasting relationships with thought leaders, as well as maximizing the effectiveness of global product launches and the teams responsible for their success” follows Moish Tov, CEO of Skila.
The Skila solutions that will be co-marketed are:
- iAdvocate: Unique technology and continuous services for building and managing lasting relationships with thought leaders based on the exchange of actionable knowledge, need and collaboration. Featuring real-time, dynamic 360-degree key opinion leader profiles; planning , targeting, and segmentation tools; meeting preparation and relationship management tools and services; and medical science liaison support and effectiveness tracking for each of these relationships.
- iLaunch: Unique technology and continuous services that enables global launch teams to maximize the effectiveness of their global team by centralizing knowledge and working as one team.
- iPerformance: Unique technology and continuous services that enable executives to achieve alignment and transparency in managing business performance across global and local brands and brand portfolios.
The Cegedim solutions that will be co-marketed are:
- IcoMed: Measures physicians' preferential attachment to products that they prescribe while evaluating the size and profile of their clientele. This personal prescribing data allows pharmaceutical companies to define physician profiles and adapt their information strategies; measure the effectiveness of their information; and perform general interest studies on the markets in which they are present or that they wish to develop;
- OneKey: A comprehensive international healthcare professional database; and
- Physician Connect. Offers an advanced solution for identifying prescribers who influence peers' prescription writing behaviors. Physician Connect evaluates the existing ties among key opinion leaders and prescribers, and makes it possible to identify local networks of influence among physicians treating a specific pathology at the local, regional or national level, for therapeutic management and continuing education purposes.
About CEGEDIM:
Founded in 1969, CEGEDIM supplies services, technological tools, databases and data flow management services. CEGEDIM’s expertise falls into two divisions. The "Healthcare and strategic data" division comprises services specifically designed for pharmaceutical companies, healthcare professionals and health insurance providers. The "Technologies and services" division covers a variety of sectors.
Established as the world leader in Pharmaceutical CRM, its historic core business, CEGEDIM employs nearly 8,000 people in 80 countries. CEGEDIM generated turnover of €756 million in 2007.
To learn more, please see our website: www.cegedim.com
Listed on Euronext Paris, compartment B – ISIN FR0000053506 – Reuters CGDM.PA – Bloomberg CGM
Media Inquiries:
Cegedim Dendrite Americas
Steve Eisenberg
Director, Corporate Communications
Tel: U.S. (908) 443-4308
Steve.eisenberg@dendrite.com
or
CEGEDIM
Aude Balleydier
Media Relations
Tel: + 33 (0)1 49 09 68 81
Aude.balleydier@cegedim.fr